{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:11:31Z","timestamp":1761487891185},"reference-count":25,"publisher":"Elsevier BV","issue":"36","license":[{"start":{"date-parts":[[2007,9,1]],"date-time":"2007-09-01T00:00:00Z","timestamp":1188604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2007,9]]},"DOI":"10.1016\/j.vaccine.2007.06.045","type":"journal-article","created":{"date-parts":[[2007,7,17]],"date-time":"2007-07-17T07:22:42Z","timestamp":1184656962000},"page":"6565-6568","source":"Crossref","is-referenced-by-count":22,"title":["BCG and HIV reconsidered: Moving the research agenda forward"],"prefix":"10.1016","volume":"25","author":[{"given":"A.C.","family":"Hesseling","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.F.","family":"Cotton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.J.","family":"Marais","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.P.","family":"Gie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.S.","family":"Schaaf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Beyers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.E.M.","family":"Fine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.J.","family":"Abrams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Godfrey-Faussett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Kuhn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2007.06.045_bib1","doi-asserted-by":"crossref","first-page":"4513","DOI":"10.1016\/j.vaccine.2007.03.030","article-title":"Comment on Hesseling, et al. \u201cThe risk of disseminated Bacille Calmette-Guerin (BCG) disease in HIV-infected children\u201d [Vaccine 25 (2006) 14\u201318]","volume":"25","author":"Tastan","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.06.045_bib2","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1111\/j.1399-3038.2005.00329.x","article-title":"Influence of Bacillus Calmette-Guerin vaccination at birth and 2 months old age on the peripheral blood T-cell subpopulations [gamma\/delta and alpha-beta T cell]","volume":"16","author":"Tastan","year":"2005","journal-title":"Pediatr Allerg Immunol"},{"key":"10.1016\/j.vaccine.2007.06.045_bib3","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0140-6736(06)68507-3","article-title":"Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness","volume":"367","author":"Trunz","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2007.06.045_bib4","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.vaccine.2006.07.020","article-title":"The risk of disseminated Bacille Calmette-Guerin (BCG) disease in HIV-infected children","volume":"25","author":"Hesseling","year":"2007","journal-title":"Vaccine"},{"journal-title":"Delayed complications of Bacille Calmette-Guerin (BCG) vaccination in HIV-infected children","year":"2005","author":"Fallo","key":"10.1016\/j.vaccine.2007.06.045_bib5"},{"key":"10.1016\/j.vaccine.2007.06.045_bib6","unstructured":"World Health Organization Weekly Epidemiological Record on 19 January 2007. No. 3, 2007, 82, 17\u201324 http:\/\/www.who.int\/wer [Accessed on 15\/06\/2007]."},{"key":"10.1016\/j.vaccine.2007.06.045_bib7","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1097\/00006454-200207000-00025","article-title":"Testing infants for human immunodeficiency virus infection","volume":"21","author":"Pugatch","year":"2002","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2007.06.045_bib8","unstructured":"World Health Organization. BCG vaccine. WHO position paper. Wkly Epidemiol Rec. 2004; 79: 27\u201338. http:\/\/www.who.int\/wer [Accessed on 15\/06\/2007]."},{"key":"10.1016\/j.vaccine.2007.06.045_bib9","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1136\/bmj.39000.486400.55","article-title":"Effect of isoniazid prophylaxis on mortality and incidence of tuberculosis in children with HIV: randomised controlled trial","volume":"334","author":"Zar","year":"2007","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2007.06.045_bib10","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1086\/338153","article-title":"Human immunodeficiency virus (HIV)-specific cellular immune responses in newborns exposed to HIV in utero","volume":"34","author":"Kuhn","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2007.06.045_bib11","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1128\/CVI.13.2.246-252.2006","article-title":"Gamma interferon production in response to Mycobacterium bovis BCG and Mycobacterium tuberculosis antigens in infants born to human immunodeficiency virus-infected mothers","volume":"13","author":"Van Rie","year":"2006","journal-title":"Clin Vaccine Immunol."},{"key":"10.1016\/j.vaccine.2007.06.045_bib12","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1086\/498029","article-title":"Does the severity of HIV disease among HIV-infected mothers affect mortality and morbidity of their uninfected infants?","volume":"41","author":"Kuhn","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2007.06.045_bib13","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/S0140-6736(07)60670-9","article-title":"Effect of age, polymicrobial disease, and maternal HIV status on treatment response and cause of severe pneumonia in South African children: a prospective descriptive study","volume":"369","author":"McNally","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2007.06.045_bib14","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/01.qai.0000218434.20404.9c","article-title":"Combining PMTCT with active case finding for tuberculosis","volume":"42","author":"Kali","year":"2006","journal-title":"J Acq Immun Def Synd"},{"key":"10.1016\/j.vaccine.2007.06.045_bib15","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1046\/j.1365-2567.2002.01366.x","article-title":"Neonatal mycobacterial specific cytotoxic T-lymphocyte and cytokine profiles in response to distinct BCG vaccination strategies","volume":"105","author":"Hussey","year":"2002","journal-title":"Immunology"},{"key":"10.1016\/j.vaccine.2007.06.045_bib16","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.4049\/jimmunol.163.4.2249","article-title":"Newborns develop a Th1-type immune response to Mycobacterium bovis bacillus Calmette-Guerin vaccination","volume":"163","author":"Marchant","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2007.06.045_bib17","doi-asserted-by":"crossref","first-page":"139","DOI":"10.2174\/157016207780077002","article-title":"Disease progression in children with vertically acquired HIV infection in sub-Saharan Africa: reviewing the need for HIV treatment","volume":"5","author":"Little","year":"2007","journal-title":"Curr HIV Res"},{"key":"10.1016\/j.vaccine.2007.06.045_bib18","doi-asserted-by":"crossref","first-page":"4713","DOI":"10.1128\/JVI.75.10.4713-4720.2001","article-title":"In vivo T-lymphocyte activation and transient reduction of viral replication in macaques infected with simian immunodeficiency virus","volume":"75","author":"Chen","year":"2001","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2007.06.045_bib19","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.4049\/jimmunol.162.4.2204","article-title":"Mycobacterium bovis bacille Calmette-Guerin enhances pathogenicity of simian immunodeficiency virus infection and accelerates progression to AIDS in macaques: a role of persistent T-cell activation in AIDS pathogenesis","volume":"162","author":"Zhou","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2007.06.045_bib20","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/S1473-3099(06)70629-6","article-title":"Mother-to-child transmission of HIV-1: timing and implications for prevention","volume":"6","author":"Kourtis","year":"2006","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2007.06.045_bib21","series-title":"Proceeding of the 11th Conference on Retroviruses and Opportunistic Infections","article-title":"Partially reverse transcribed HIV genome in uninfected HIV-exposed infants","author":"Lee","year":"2004"},{"key":"10.1016\/j.vaccine.2007.06.045_bib22","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1128\/JVI.66.3.1717-1725.1992","article-title":"Incompletely reverse transcribed HIV type 1 genomes in quiescent cells can function as intermediates in the retroviral life cycle","volume":"66","author":"Zack","year":"1992","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2007.06.045_bib23","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1097\/01.qai.0000225009.30698.ce","article-title":"In vivo effects of HIV-1 exposure in the presence and absence of single-dose nevirapine on cellular plasma activation markers of infants born to HIV-1-seropositive mothers","volume":"42","author":"Schramm","year":"2006","journal-title":"J Acq Immun Def Synd"},{"key":"10.1016\/j.vaccine.2007.06.045_bib24","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1136\/bmj.321.7274.1435","article-title":"Routine vaccinations and child survival: follow up study in Guinea-Bissau, West Africa","volume":"321","author":"Kristensen","year":"2000","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2007.06.045_bib25","doi-asserted-by":"crossref","first-page":"919","DOI":"10.4049\/jimmunol.168.2.919","article-title":"Influence of Mycobacterium bovis bacillus Calmette-Guerin on antibody and cytokine responses to human neonatal vaccination","volume":"168","author":"Ota","year":"2002","journal-title":"J Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07007311?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07007311?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,13]],"date-time":"2023-05-13T07:45:23Z","timestamp":1683963923000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X07007311"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9]]},"references-count":25,"journal-issue":{"issue":"36","published-print":{"date-parts":[[2007,9]]}},"alternative-id":["S0264410X07007311"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2007.06.045","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2007,9]]}}}